AE Wealth Management LLC
13F filer · CIK 0001697723Reported Aug 3, 2026
13F portfolio value$21.5BU.S. long equity reported on 13F
Positions1,059Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight18.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 3, 20261,059 positions | |||||
| $770M | 3.59% | 0.02% | +6.8% | Q3 2017 | |
| $742M | 3.46% | 0.02% | +6.1% | Q4 2016 | |
| $510M | 2.38% | 0.02% | +6.4% | Q4 2016 | |
| $410M | 1.91% | 0.02% | +7.8% | Q4 2016 | |
| $345M | 1.61% | 0.01% | +10.5% | Q1 2017 | |
| $298M | 1.39% | 0.02% | +8.7% | Q4 2017 | |
| $293M | 1.37% | 0.02% | -8.1% | Q2 2018 | |
| $212M | 0.99% | Not reported | +4.8% | Q4 2016 | |
| $189M | 0.88% | 0.02% | -14.1% | Q2 2019 | |
| $171M | 0.80% | 0.03% | +16.3% | Q4 2017 | |
| $165M | 0.77% | 0.02% | +8.7% | Q4 2016 | |
| OBONEZOne Bio, Corp. | $160M | 0.75% | Not reported | +128.1% | Q1 2025 |
| $154M | 0.72% | Not reported | +67630.3% | Q2 2024 | |
| $150M | 0.70% | Not reported | +8.2% | Q4 2016 | |
| $148M | 0.69% | 0.03% | -13.6% | Q4 2016 | |
| $143M | 0.67% | 0.02% | +2.9% | Q4 2016 | |
| $127M | 0.59% | 0.01% | +6.5% | Q2 2017 | |
| $117M | 0.55% | 0.01% | +14.3% | Q4 2016 | |
| $115M | 0.53% | Not reported | +61.5% | Q4 2016 | |
| $113M | 0.53% | 0.02% | +9.5% | Q1 2017 | |
| $99.8M | 0.47% | 0.02% | -2.9% | Q4 2017 | |
| $96.6M | 0.45% | 0.05% | +3.6% | Q4 2016 | |
| $90.9M | 0.42% | 0.03% | -23.1% | Q4 2016 | |
| $89.3M | 0.42% | 0.02% | +7.8% | Q4 2016 | |
| $87.6M | 0.41% | 0.03% | +51.5% | Q4 2016 | |
| $85M | 0.40% | 0.02% | -20.1% | Q4 2017 | |
| $80.9M | 0.38% | 0.02% | +7.5% | Q4 2016 | |
| $80.8M | 0.38% | 0.02% | +29.0% | Q4 2016 | |
| $77.9M | 0.36% | Not reported | +26.4% | Q1 2017 | |
| $77M | 0.36% | 0.03% | +0.9% | Q1 2018 | |
| $76.8M | 0.36% | 0.01% | +6.7% | Q4 2016 | |
| $73.8M | 0.34% | 0.02% | +6.8% | Q4 2016 | |
| $71.1M | 0.33% | 0.03% | +16.8% | Q4 2020 | |
| $70.1M | 0.33% | 0.03% | -7.7% | Q4 2016 | |
| $67.6M | 0.31% | 6.11% | +12.0% | Q4 2023 | |
| $64.4M | 0.30% | 0.03% | +14.1% | Q1 2017 | |
| $63.6M | 0.30% | 0.06% | +84.9% | Q1 2017 | |
| $62.7M | 0.29% | 0.01% | +7.3% | Q4 2016 | |
| $62.2M | 0.29% | 0.01% | +27.4% | Q4 2016 | |
| $62M | 0.29% | 0.17% | +414.0% | Q4 2016 | |
| $61.5M | 0.29% | Not reported | +8.0% | Q4 2022 | |
| $60.8M | 0.28% | 0.02% | -1.1% | Q4 2017 | |
| $60.6M | 0.28% | Not reported | -3.2% | Q4 2016 | |
| $59.7M | 0.28% | 0.02% | +12.5% | Q2 2017 | |
| $59.3M | 0.28% | 0.01% | +118.0% | Q4 2016 | |
| $56.3M | 0.26% | 0.02% | +1.3% | Q4 2016 | |
| $56M | 0.26% | Not reported | +2.7% | Q2 2018 | |
| $54.8M | 0.26% | 0.08% | +49.9% | Q2 2018 | |
| $54.6M | 0.25% | 0.03% | +8.5% | Q2 2019 | |
| $50.9M | 0.24% | 0.07% | +9.7% | Q4 2016 | |
| Q1 2026Reported May 13, 2026987 positions | |||||
| $629M | 3.40% | 0.01% | +17.3% | Q3 2017 | |
| $614M | 3.32% | 0.02% | +12.4% | Q4 2016 | |
| $475M | 2.57% | 0.02% | +24.5% | Q4 2016 | |
| $333M | 1.80% | 0.01% | +5.9% | Q4 2016 | |
| $251M | 1.36% | 0.01% | -2.0% | Q1 2017 | |
| $224M | 1.21% | 0.02% | +17.3% | Q4 2017 | |
| $206M | 1.11% | Not reported | +3.5% | Q4 2016 | |
| $170M | 0.92% | 0.02% | +3.4% | Q4 2016 | |
| $136M | 0.74% | 0.02% | -10.2% | Q4 2016 | |
| $134M | 0.72% | 0.02% | +11.7% | Q4 2016 | |
| $132M | 0.72% | Not reported | +3.9% | Q4 2016 | |
| $113M | 0.61% | 0.04% | +9.4% | Q4 2016 | |
| $112M | 0.61% | 0.01% | +3.8% | Q4 2016 | |
| $108M | 0.58% | 0.04% | +24.4% | Q4 2016 | |
| $107M | 0.58% | 0.05% | +20.9% | Q4 2016 | |
| $105M | 0.57% | 0.01% | +12.8% | Q2 2017 | |
| $100M | 0.54% | 0.02% | +5.6% | Q4 2017 | |
| $93.4M | 0.51% | 0.02% | -13.9% | Q2 2018 | |
| $91.3M | 0.49% | 0.02% | +7.0% | Q1 2017 | |
| $77.1M | 0.42% | 0.02% | +17.1% | Q2 2019 | |
| $76.4M | 0.41% | 0.02% | +2.2% | Q4 2020 | |
| $74.1M | 0.40% | 0.02% | -21.6% | Q4 2016 | |
| $72.2M | 0.39% | 0.02% | -34.2% | Q4 2016 | |
| $71.6M | 0.39% | 0.02% | +12.0% | Q4 2016 | |
| $69.6M | 0.38% | 0.03% | -14.4% | Q4 2017 | |
| $65.4M | 0.35% | 0.03% | +141.8% | Q4 2016 | |
| OBONEZOne Bio, Corp. | $63.6M | 0.34% | Not reported | +4.6% | Q1 2025 |
| $61.8M | 0.33% | 0.03% | +89.5% | Q1 2018 | |
| $61.7M | 0.33% | Not reported | -43.3% | Q4 2016 | |
| $60.5M | 0.33% | 0.05% | +1767.0% | Q2 2018 | |
| $60.5M | 0.33% | 5.45% | +5.1% | Q4 2023 | |
| $59.4M | 0.32% | 0.01% | -20.1% | Q1 2017 | |
| $59.2M | 0.32% | Not reported | +144.8% | Q1 2017 | |
| $59.1M | 0.32% | 0.02% | -19.6% | Q4 2016 | |
| $58.7M | 0.32% | 0.01% | +69.8% | Q4 2016 | |
| $55.4M | 0.30% | Not reported | +0.8% | Q4 2016 | |
| $55.2M | 0.30% | 0.01% | -33.3% | Q4 2016 | |
| $54.8M | 0.30% | 0.03% | +16.1% | Q1 2017 | |
| $54.6M | 0.30% | 0.01% | +18.7% | Q4 2017 | |
| $52.7M | 0.28% | 0.03% | -23.1% | Q4 2016 | |
| $52.5M | 0.28% | 0.02% | +23.0% | Q4 2017 | |
| $51.8M | 0.28% | 0.03% | +19.7% | Q4 2018 | |
| $51.8M | 0.28% | 0.02% | +43.0% | Q4 2016 | |
| $51.1M | 0.28% | 0.02% | +5.1% | Q2 2017 | |
| $50.7M | 0.27% | 0.04% | +144.8% | Q1 2019 | |
| $48.4M | 0.26% | 0.02% | +89.8% | Q4 2017 | |
| $46.8M | 0.25% | 0.03% | +14.5% | Q4 2016 | |
| $45.1M | 0.24% | 0.02% | +7.3% | Q2 2020 | |
| $44.4M | 0.24% | 0.06% | +11.2% | Q4 2016 | |
| $44.3M | 0.24% | 0.06% | +25.4% | Q4 2016 | |
| Q4 2025Reported Jan 26, 2026932 positions | |||||
| $585M | 3.36% | 0.01% | +7.0% | Q4 2016 | |
| $573M | 3.29% | 0.01% | +9.8% | Q3 2017 | |
| $499M | 2.86% | 0.01% | +17.2% | Q4 2016 | |
| $348M | 2.00% | 0.01% | +10.0% | Q4 2016 | |
| $279M | 1.60% | 0.01% | -3.6% | Q1 2017 | |
| $229M | 1.32% | Not reported | +11.7% | Q4 2016 | |
| $214M | 1.23% | 0.01% | +4.4% | Q4 2017 | |
| $166M | 0.96% | 0.02% | +8.1% | Q4 2016 | |
| $134M | 0.77% | Not reported | -4.4% | Q4 2016 | |
| $117M | 0.67% | 0.02% | +4.6% | Q4 2016 | |
| $114M | 0.66% | Not reported | +17.2% | Q4 2016 | |
| $113M | 0.65% | 0.01% | +2.1% | Q2 2017 | |
| $108M | 0.62% | 0.02% | +44.2% | Q4 2017 | |
| $103M | 0.59% | 0.03% | +11.8% | Q4 2016 | |
| $101M | 0.58% | 0.02% | +1.8% | Q4 2016 | |
| $99M | 0.57% | 0.02% | +14.0% | Q1 2017 | |
| $97.1M | 0.56% | 0.01% | +56.6% | Q4 2016 | |
| $96.7M | 0.56% | 0.01% | +4.1% | Q4 2016 | |
| $93.9M | 0.54% | 0.03% | -1.6% | Q4 2016 | |
| $91.7M | 0.53% | 0.03% | -9.9% | Q2 2018 | |
| $90.8M | 0.52% | 0.02% | +3.0% | Q4 2020 | |
| $87.2M | 0.50% | 0.04% | -10.0% | Q4 2016 | |
| $84.2M | 0.48% | 0.03% | +56.3% | Q4 2016 | |
| $83M | 0.48% | 0.02% | +58.1% | Q4 2016 | |
| $80.9M | 0.46% | 0.03% | +12.7% | Q4 2016 | |
| $69.3M | 0.40% | 0.02% | +0.4% | Q2 2019 | |
| $67.2M | 0.39% | 0.02% | +2.7% | Q4 2016 | |
| $64.4M | 0.37% | 0.02% | +77.3% | Q1 2017 | |
| OBONEZOne Bio, Corp. | $63.1M | 0.36% | Not reported | +3.8% | Q1 2025 |
| $61.4M | 0.35% | 0.02% | +21.3% | Q4 2018 | |
| $61.2M | 0.35% | 0.03% | +14.0% | Q4 2017 | |
| $59M | 0.34% | 0.02% | +55.3% | Q3 2021 | |
| $58M | 0.33% | 0.02% | -23.8% | Q1 2019 | |
| $57.6M | 0.33% | 5.19% | +4.4% | Q4 2023 | |
| $56.9M | 0.33% | 0.02% | +24.8% | Q2 2017 | |
| $55.6M | 0.32% | 0.03% | +15.1% | Q4 2016 | |
| $53.2M | 0.31% | Not reported | +2.9% | Q4 2016 | |
| $47.8M | 0.27% | Not reported | +2.1% | Q2 2018 | |
| $47.3M | 0.27% | Not reported | +23.8% | Q4 2022 | |
| $46.6M | 0.27% | 0.03% | -6.5% | Q4 2016 | |
| $45.8M | 0.26% | 0.01% | +15.0% | Q4 2016 | |
| $44.9M | 0.26% | 0.01% | -0.1% | Q4 2017 | |
| $43.9M | 0.25% | 0.02% | +21.7% | Q1 2017 | |
| $40.8M | 0.23% | 0.51% | +45.1% | Q4 2022 | |
| $40M | 0.23% | 0.02% | +95.5% | Q2 2020 | |
| $37.9M | 0.22% | 0.01% | -14.6% | Q4 2016 | |
| $37.8M | 0.22% | 0.02% | +2.1% | Q2 2019 | |
| $37M | 0.21% | 0.04% | -2.9% | Q4 2016 | |
| $36.2M | 0.21% | 0.03% | +17.5% | Q4 2016 | |
| $35.4M | 0.20% | 0.37% | +30.6% | Q3 2017 | |
| Q3 2025Reported Nov 3, 2025863 positions | |||||
| $522M | 3.33% | 0.01% | +1.8% | Q3 2017 | |
| $512M | 3.26% | 0.01% | +11.4% | Q4 2016 | |
| $456M | 2.91% | 0.01% | +7.1% | Q4 2016 | |
| $301M | 1.92% | 0.01% | +12.7% | Q4 2016 | |
| $229M | 1.46% | Not reported | +4.4% | Q4 2016 | |
| $225M | 1.43% | 0.01% | +8.5% | Q1 2017 | |
| $195M | 1.24% | 0.01% | +4.6% | Q4 2017 | |
| $151M | 0.96% | 0.02% | +11.6% | Q4 2016 | |
| $140M | 0.89% | Not reported | +12.6% | Q4 2016 | |
| $110M | 0.70% | 0.01% | +4.1% | Q2 2017 | |
| $104M | 0.67% | 0.02% | +9.5% | Q4 2016 | |
| $102M | 0.65% | 0.03% | +15.3% | Q4 2016 | |
| $96.3M | 0.61% | 0.04% | +12.9% | Q4 2016 | |
| $95.2M | 0.61% | Not reported | +5.2% | Q4 2016 | |
| $90.5M | 0.58% | 0.02% | +6.5% | Q4 2020 | |
| $89.3M | 0.57% | 0.02% | +11.6% | Q4 2016 | |
| $84.6M | 0.54% | 0.01% | +11.0% | Q1 2017 | |
| $81.5M | 0.52% | 0.03% | +13.6% | Q4 2016 | |
| $74.8M | 0.48% | 0.01% | +11.7% | Q4 2017 | |
| $73.1M | 0.47% | 0.02% | +11.2% | Q4 2016 | |
| $68.9M | 0.44% | 0.03% | +5.4% | Q1 2019 | |
| $66.3M | 0.42% | 0.02% | +7.0% | Q4 2016 | |
| $66M | 0.42% | 0.01% | +26.7% | Q4 2016 | |
| OBONEZOne Bio, Corp. | $62.1M | 0.40% | Not reported | +59.3% | Q1 2025 |
| $59.7M | 0.38% | 0.03% | +6.1% | Q2 2018 | |
| $57.5M | 0.37% | 0.01% | +7.3% | Q4 2016 | |
| $57.5M | 0.37% | 0.01% | +9.2% | Q4 2017 | |
| $57.4M | 0.37% | 0.01% | +17.5% | Q4 2016 | |
| $56.7M | 0.36% | 0.03% | +5.3% | Q4 2016 | |
| $55.3M | 0.35% | 4.97% | +5.7% | Q4 2023 | |
| $54.5M | 0.35% | 0.02% | +4.4% | Q4 2016 | |
| $52.2M | 0.33% | 0.01% | +3.4% | Q4 2016 | |
| $52.2M | 0.33% | 0.02% | +6.3% | Q2 2019 | |
| $52.1M | 0.33% | 0.03% | +11.9% | Q4 2016 | |
| $51.3M | 0.33% | Not reported | +0.4% | Q4 2016 | |
| $49.2M | 0.31% | 0.01% | +10.8% | Q4 2016 | |
| $46.9M | 0.30% | 0.05% | +4.5% | Q1 2019 | |
| $45.8M | 0.29% | Not reported | +7.9% | Q2 2018 | |
| $45.3M | 0.29% | 0.02% | +11.5% | Q4 2018 | |
| $43.7M | 0.28% | 0.04% | +2.5% | Q4 2016 | |
| $43.1M | 0.27% | 0.09% | +4.8% | Q2 2018 | |
| $42.8M | 0.27% | 0.03% | +15.5% | Q4 2017 | |
| $41.3M | 0.26% | 0.01% | +1.7% | Q4 2016 | |
| $41M | 0.26% | 0.02% | +15.8% | Q2 2017 | |
| $39M | 0.25% | 0.01% | +21.7% | Q1 2017 | |
| $38.6M | 0.25% | Not reported | +10.9% | Q4 2022 | |
| $37.1M | 0.24% | 0.01% | +10.7% | Q3 2021 | |
| $34.5M | 0.22% | 0.02% | +1.9% | Q2 2019 | |
| $34M | 0.22% | 0.02% | +16.4% | Q4 2016 | |
| $33.5M | 0.21% | 0.02% | +8.4% | Q4 2018 | |
Premium opens every quarter this fund has filed